In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome

In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome

Metabolic syndrome is a set of risk factors that consist of abdominal obesity, arterial hypertension, alterations in the lipid profile, and hyperglycemia. The current therapeutic strategy includes polypharmacy, using three or more drugs to control each syndrome component. However, this approach has...

Full description

Bibliographic Details
Main Authors: Edwin Chávez-Gutiérrez, Matilda Martínez-Arellanes, Montserrat Murillo-López, María Fernanda Medina-Guzmán, Laila Mobarak-Richaud, Karen Pelcastre-Guzmán, Osvaldo Javier Quintana-Romero, Armando Ariza-Castolo, María del Rosario Ayala-Moreno, Juan Rodrigo Salazar, Christian Guerra-Araiza, Lorena Rodríguez-Páez, Rodolfo Pinto-Almazán, Marco A. Loza-Mejía
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
metabolic syndrome
multitarget drugs
molecular docking
anthranilic acid
Online Access:https://www.mdpi.com/1424-8247/15/12/1461

Internet

https://www.mdpi.com/1424-8247/15/12/1461

Similar Items